Clearstead Advisors’s Atrion Corp ATRI Stock Holding History

Clearstead Advisors’s Portfolio ATRI Stock Details ATRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4	Closed	-$3K	–	1477
2022 Q1	$3K	Buy	+4	New	+$2.73K	﹤0.01%	1174

Other funds holding ATRI

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clearstead Advisors's ATRI Position: Q2 2022 in Review

Clearstead Advisors sold out of Atrion Corp (ATRI) in Q2 2022, closing a stake of 4 shares — an estimated $3K sold.

Clearstead Advisors first reported a position in ATRI in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 127 funds tracked by Wall St. Rank hold ATRI as of Q2 2022.

Clearstead Advisors reported no remaining Atrion Corp position as of Q2 2022 after selling out during the quarter.
Clearstead Advisors sold 4 Atrion Corp shares in Q2 2022, an estimated $3K.
Clearstead Advisors first reported a position in Atrion Corp in Q1 2022 and held it in 1 quarter.
Clearstead Advisors's Atrion Corp position peaked at $3K in Q1 2022.
127 funds tracked by Wall St. Rank held Atrion Corp as of Q2 2022.

Based on Clearstead Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.